With Pfizer’s stock down sharply, an activist investor is pushing for something new from the CEO who spurred the company to ...

How an unelected bureaucrat seized control of the European Union and now dictates the continent’s policy on everything from ...

When facing complex global challenges, ethical leadership plays a crucial role in determining whether companies prioritise ...

Pfizer’s stock has dropped over 50% since its pandemic peak, following a series of costly acquisitions. Read and D’Amelio ...

Now, despite playing no formal role in the battle between Pfizer and Starboard, Guggenheim has found itself in the crossfire of one of the messiest activist campaigns in recent Wall Street memory.

Pfizer Inc. and Albert Bourla got the upper hand in an early skirmish against Starboard Value LP — but the drugmaker and its ...

Pfizer appointed a former chief executive officer at Vanguard, the drug giant's biggest investor, to its board on Tuesday as ...

Pfizer Inc. (NYSE: PFE) today announced the election of Mortimer ("Tim") J. Buckley to its Board of Directors, effective ...

Will this clash between a major shareholder and management, current and former, harm the stock? Or is the situation merely an ...

With headquarters in New York, Pfizer is a member of the benchmark S&P 500 Index ($SPX), and has 36 manufacturing sites worldwide. After finding massive success during the COVID-19 pandemic with its ...

Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...